Chinese Therapeutics Startup Harbour BioMed Musters US$102.8M Series C
Harbour BioMed takes its capital pool to well over US$300 million with this round Shanghai-based biotech startup Harbour BioMed has rounded off its Series C financing with a haul of US$102.8 million, the company announced in a statement today. Hudson Bay Capital led the round, with participation from OrbiMed, Country Garden VC, GTJA Investment Group, […]
Chinese Therapeutics Startup Harbour BioMed Musters US$102.8M Series C Read More ยป
Harbour BioMed takes its capital pool to well over US$300 million with this round Shanghai-based biotech startup Harbour BioMed has rounded off its Series C financing with a haul of US$102.8 million, the company announced in a statement today. Hudson Bay Capital led the round, with participation from OrbiMed, Country Garden VC, GTJA Investment Group,




